subscribe
 

Prosensa achieves orphan drug status on its entire Duchenne muscular dystrophy portfolio

Prosensa has achieved orphan drug designation in the EU and the US for all of its compounds for the treatment of Duchenne muscular dystrophy (DMD).

New salmon peptone – sustainable marine resources used in the production of high-value biotech products

A project has successfully examined the commercial viability of the use of marine derived peptones in the production of high value products...

New treatment could combat deadly chemical agents

An enzyme treatment which could neutralise the effects of lethal chemicals responsible for the deaths of hundreds of thousands of people...

Fleming Europe's Global SFE Forum 2013

Identifying and addressing physicians' differing views on the 'right experience' has become one of the top priorities for pharma & biotech companies implementing new commercial models. Find out more at the Global SFE Forum in Amsterdam on ...

Antibiotics based on a new principle may defeat MRSA

Scientists at Karolinska Institutet in Sweden have presented a new principle for fighting bacterial infections, in other words, a new type of antibiotic, in the medical journal FASEB. The new antibiotic mechanism is based on selectively...

Roche and IMI promote use of stem cell technology to enhance drug development

Roche and the Innovative Medicines Initiative have announced the launch of StemBANCC, a new academic–industry partnership that unites ten pharmaceutical companies and 23 academic institutions.

New study shows how copper restricts the spread of global antibiotic-resistant infections

New research from the University of Southampton has shown that copper can prevent horizontal transmission of genes, which has contributed to the increasing number of antibiotic-resistant infections worldwide.

New Queen’s University plasma jet gives ‘cold’ shoulder to superbugs

Scientists at Queen’s University Belfast have developed a new technique which has the potential to kill off hospital superbugs like Pseudomonas aeruginosa, C. difficile and MRSA.

8th Annual Quality & OPEX in Pharma & Biotech

Leading pharma players such as Pfizer, Roche, Sanofi, Merck, Novartis, Genzyme, Teva, etc. understand that manufacturing quality is becoming a key driver in successful and timely product launches. Find solutions to overcome the challenges...

Reversible oxygen-sensing ‘switching’ mechanism discovered

Bacteria that cause disease in humans have a ‘reversible switching mechanism’ that allows them to adapt to environments lacking oxygen, scientists at the University of East Anglia (UEA) have found.

New bacteria resistant materials discovered

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital...

Portable system for aspiration and disposal of biological waste

The VACUSIP from INTEGRA provides an ideal benchtop solution for the safe aspiration and disposal of small volumes of liquid waste in...

SP Scientific announces 2012 Lyophilisation webinars

SP Scientific has announced its 2012 program of free educational webinars delivered by industry experts on topics in Lyophilisation and Freeze Drying.

Roche launches 454 sequencing assays

Roche has announced the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes using the company’s 454 GS Junior and GS FLX...

Engineered cornea more resistant to chemical injury

A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.

Sartorius Stedim Biotech launches initiative to enhance supply chain security

Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, has substantially extended its supply chain security practices.

A permanent cure for type 1 diabetes?

Type 1 diabetes is the most prevalent metabolic disorder among young people. The origins of the disease remain unknown, but an effective...

Antibiotic resistance: Structures of a multidrug efflux pump in complex with antibiotics

A team at the Institute of Biochemistry of the Goethe University Frankfurt, used X-ray crystallography to solve high resolution structures of the membrane protein AcrB in complex with multiple antibiotics.

DNA origami puts a smart lid on solid-state nanopore sensors

The latest advance in solid-state nanopore sensors - devices that are made with standard tools of the semiconductor industry yet can offer...

Unique adaptations to a symbiotic lifestyle reveal novel targets for aphid insecticides

Aphids are pests that cause millions of pounds of damage to crops in the UK, but new research led by biologists at the University of York reveals potential new targets for aphid-specific insecticides.

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe